Next Article in Journal
Chronic Adolescent Restraint Stress Downregulates miRNA-200a Expression in Male and Female C57BL/6J and BALB/cJ Mice
Previous Article in Journal
PON1 rs662, rs854560 and TRIB1 rs17321515, rs2954029 Gene Polymorphisms Are Associated with Lipid Parameters in Patients with Unstable Angina
Previous Article in Special Issue
Clinical Decision Analysis of Genetic Evaluation and Testing in 1013 Intensive Care Unit Infants with Congenital Heart Defects Supports Universal Genetic Testing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

Congenital Heart Disease and Genetic Changes in Folate/Methionine Cycles

by
Nataša Karas Kuželički
1,* and
Bojan Doljak
2
1
Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia
2
Department of Pharmaceutical Biology, Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Genes 2024, 15(7), 872; https://doi.org/10.3390/genes15070872 (registering DOI)
Submission received: 3 May 2024 / Revised: 29 June 2024 / Accepted: 30 June 2024 / Published: 2 July 2024
(This article belongs to the Special Issue Genetics, Genomics and Precision Medicine in Heart Diseases)

Abstract

Congenital heart disease is one of the most common congenital malformations and thus represents a considerable public health burden. Hence, the identification of individuals and families with an increased genetic predisposition to congenital heart disease (CHD) and its possible prevention is important. Even though CHD is associated with the lack of folate during early pregnancy, the genetic background of folate and methionine metabolism perturbations and their influence on CHD risk is not clear. While some genes, such as those coding for cytosolic enzymes of folate/methionine cycles, have been extensively studied, genetic studies of folate transporters (de)glutamation enzymes and mitochondrial enzymes of the folate cycle are lacking. Among genes coding for cytoplasmic enzymes of the folate cycle, MTHFR, MTHFD1, MTR, and MTRR have the strongest association with CHD, while among genes for enzymes of the methionine cycle BHMT and BHMT2 are the most prominent. Among mitochondrial folate cycle enzymes, MTHFD2 plays the most important role in CHD formation, while FPGS was identified as important in the group of (de)glutamation enzymes. Among transporters, the strongest association with CHD was demonstrated for SLC19A1.
Keywords: congenital heart disease; genetics; folate; methionine; transporters congenital heart disease; genetics; folate; methionine; transporters

Share and Cite

MDPI and ACS Style

Karas Kuželički, N.; Doljak, B. Congenital Heart Disease and Genetic Changes in Folate/Methionine Cycles. Genes 2024, 15, 872. https://doi.org/10.3390/genes15070872

AMA Style

Karas Kuželički N, Doljak B. Congenital Heart Disease and Genetic Changes in Folate/Methionine Cycles. Genes. 2024; 15(7):872. https://doi.org/10.3390/genes15070872

Chicago/Turabian Style

Karas Kuželički, Nataša, and Bojan Doljak. 2024. "Congenital Heart Disease and Genetic Changes in Folate/Methionine Cycles" Genes 15, no. 7: 872. https://doi.org/10.3390/genes15070872

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop